June 2020 in “Medicinskij alfavit” In this clinical study of 98 patients with focal alopecia, combined laser therapy, which included laser plasma therapy and percutaneous laser irradiation of blood, was reported to alleviate inflammation, promote hair growth, and restore trace elements in affected areas.
December 2024 in “Medical alphabet” This study concludes that a combined therapy of erbium laser, transcutaneous laser blood irradiation, and minoxidil had the greatest impact on improving microcirculation efficiency in patients with diffuse telogen effluvium.
November 2024 in “Fizioterapevt (Physiotherapist)” In this study, a combined treatment method using fractional laser therapy, intravenous blood irradiation, and minoxidil significantly improved hair loss in patients with diffuse telogenetic alopecia compared to other treatments, showing a 36.9% improvement in mild cases and a 70.8% improvement in severe cases.
November 2024 in “Fizioterapevt (Physiotherapist)” This study found that combining fractional laser therapy, intravenous blood irradiation, and minoxidil significantly improved the psycho-emotional state and quality of life in patients with diffuse telogen effluvium, performing better than individual treatments alone, as measured by the DIQOL index.
November 2025 in “Bioactive Materials” In this study, researchers developed a DNA/GelMA-based cryogel platform that uses phototherapy to combat MRSA infection and promote scarless wound healing, showing enhanced bactericidal activity, tissue regeneration, and anti-inflammatory effects in vivo, suggesting a promising approach for treating infected skin wounds.
